Sato Y, Sumikawa H, Shibaki R, Morimoto T, et al. Drug-related pneumonitis induced by osimertinib as first-line treatment for EGFR-positive non-small cell lung cancer: a real-world setting. Chest 2022 Jun 1. pii: S0012-3692(22)01068-6. doi: 10.1016/j.chest.2022.
PMID: 35661746